Summary
This prediction ended on 05.11.21 with a price of €39.30. With a performance of 189.29% the BUY prediction by Steppenwolf0815 was a big success. Steppenwolf0815 has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -3.233% | -3.233% | -64.953% | -84.701% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by Steppenwolf0815 for this prediction
In the thread Evotec AG diskutieren
Evotec Langfristanlage
Eine der wenigen Biotechaktien die jetzt schon schwarze Zahlen schreiben. In den nächsten Monaten wird sich der Kurs langsam aber stetig nach oben bewegen. Ob die 30€ nach einem oder zwei Jahren erreicht werden, ist für mich nicht relevant. 100% Gewinn sind denke ich auf jeden Fall wohl drin. Geduld ist der Schlüssel zum Erfolg.
In the thread Trading Evotec AG